Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

Blood (2015) 126 (23): 4226.

https://doi.org/10.1182/blood.V126.23.4226.4226

Published: 2015

Journal Articles

A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma

Ajai Chari, MD, Hearn J. Cho, MD PhD, Samir Parekh, MD, Amishi Dhadiwal, Katarzyna Garcia, MS, Natalie Belostotsky, Donna Catamero, NP, Arlynn Brion, Lauren Cardone, Juliet Escalaon, Daniel Verina, Moon-hee Yum, Lisa La, MS, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD

Blood (2014) 124 (21): 3486.

https://doi.org/10.1182/blood.V124.21.3486.3486

Published: 2014

Journal Articles

Ponatinib Safety and Efficacy in Japanese Patients with Philadelphia Positive Leukemia: Update of a Phase 1/2 Study

Taiichi Kyo, Arinobu Tojo, MD PhD, Kazuhito Yamamoto, Naoto Takahashi, Hirohisa Nakamae, Yukio Kobayashi, Tetsuzo Tauchi, Shinichiro Okamoto, Koichi Miyamura, Hiromi Iwasaki, MD PhD, Kiyohiko Hatake, MD PhD, Itaru Matsumura, Noriko Usui, Kumiko Yanase, Simin Hu, Tomoki Naoe, Kazuma Ohyashiki

Blood (2014) 124 (21): 5541.

https://doi.org/10.1182/blood.V124.21.5541.5541

Published: 2014

Journal Articles

Evaluation Of Electrocardiogram Parameters In Patients With Breast and Lung Cancer Treated With Chemotherapy and Lipegfilgrastim Or Pegfilgrastim

Andreas Lammerich, Igor Bondarenko, Udo Müller

Blood (2013) 122 (21): 4856.

https://doi.org/10.1182/blood.V122.21.4856.4856

Published: 2013

Journal Articles

A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma

Noa Biran, MD, Samira Shahnaz, MD, Sundar Jagannath, MD, Hearn J. Cho, MD, PhD, Keren Osman, MD, Samir Parekh, MD, Danielle Choi, RN, Katarzyna Garcia, MS, Donna Catamero, NP, Lisa La, MS, Jude Gullie, BA, Elaine Chan, BS, Ajai Chari, MD

Blood (2013) 122 (21): 5392.

https://doi.org/10.1182/blood.V122.21.5392.5392

Published: 2013

Journal Articles

Analysis of the Potential Effect of Ponatinib on the QTc Interval in Patients with Refractory Hematologic Malignancies

Daryl Sonnichsen, David Dorer, Jorge E. Cortes, Moshe Talpaz, MD, Michael W. Deininger, MD, PhD, Neil Shah, MD, PhD, Hagop M. Kantarjian, Dale Bixby, MD PhD, Michael J. Mauro, MD, Ian W. Flinn, MD, PhD, Jeffrey Litwin, MD, Christopher D. Turner, MD, FAAP, Frank Haluska, MD, PhD

Blood (2011) 118 (21): 4441.

https://doi.org/10.1182/blood.V118.21.4441.4441

Published: 2011

Journal Articles

Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Oliver G. Ottmann, MD, PhD, Daniel J. DeAngelo, MD, PhD, Guillermo Garcia-Manero, Michael Lübbert, Anand Jillella, MD, Mikkael A. Sekeres, MD, MS, Anita Zahlten, PhD, Margaret Squier, MD, PhD, Suddhasatta Acharyya, PhD, Ivo J. Winiger, MD, Pierre Fenaux, MD, PhD

Blood (2011) 118 (21): 459.

https://doi.org/10.1182/blood.V118.21.459.459

Published: 2011

Journal Articles

Systematic Assessment of Potential Cardiac Effects of the Novel Histone Deacetylase (HDAC) Inhibitor Romidepsin.

Christopher Cabell, M.D., M.H.S., F.A.C.C., Susan Bates, MD, Richard Piekarz, MD, PhD, Sean Whittaker, MD, FRCP, Youn H Kim, MD, Michelle Currie, C. J Godfrey, Ph.D., Christopher Schoonmaker, Ph.D., Jean Nichols, PhD, Darrell Nix, Ph.D., Howard A. Burris, MD

Blood (2009) 114 (22): 3709.

https://doi.org/10.1182/blood.V114.22.3709.3709

Published: 2009

Journal Articles

All-Trans Retinoic Acid Syndrome Mimicking ST Segment Elevation Myocardial Infarction.

Arif H. Kamal, MD, Danielle M. Henkel, MD, Ayalew Tefferi, MD, Richard S. Wright, MD

Blood (2006) 108 (11): 4571.

https://doi.org/10.1182/blood.V108.11.4571.4571

Published: 2006

Journal Articles

Stem Cell Transplantation in Patients with Preexisting Coronary Artery Disease.

George Chen, MD, George Carrum, MD, Uday Popat, MD

Blood (2004) 104 (11): 5028.

https://doi.org/10.1182/blood.V104.11.5028.5028

Published: 2004

NARROW

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma

Ponatinib Safety and Efficacy in Japanese Patients with Philadelphia Positive Leukemia: Update of a Phase 1/2 Study

Evaluation Of Electrocardiogram Parameters In Patients With Breast and Lung Cancer Treated With Chemotherapy and Lipegfilgrastim Or Pegfilgrastim

A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma

Analysis of the Potential Effect of Ponatinib on the QTc Interval in Patients with Refractory Hematologic Malignancies

Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Systematic Assessment of Potential Cardiac Effects of the Novel Histone Deacetylase (HDAC) Inhibitor Romidepsin.

All-Trans Retinoic Acid Syndrome Mimicking ST Segment Elevation Myocardial Infarction.

Stem Cell Transplantation in Patients with Preexisting Coronary Artery Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only